🎉 M&A multiples are live!
Check it out!

AbCellera Valuation Multiples

Discover revenue and EBITDA valuation multiples for AbCellera and other public comps.

See AbCellera Valuation Multiples

AbCellera Overview

About AbCellera

AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company’s experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.


Founded

2012

HQ

United States of America
Employees

586

Website

abcellera.com

Financials

LTM Revenue $32.8M

LTM EBITDA -$224M

EV

$344M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

AbCellera Financials

AbCellera has a last 12-month revenue of $32.8M and a last 12-month EBITDA of -$224M.

In the most recent fiscal year, AbCellera achieved revenue of $38.0M and an EBITDA of -$192M.

AbCellera expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See AbCellera valuation multiples based on analyst estimates

AbCellera P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $485M $38.0M $31.6M $32.8M XXX
Gross Profit $330M $419M $38.0M XXX XXX
Gross Margin 68% 1102% 120% XXX XXX
EBITDA $276M -$192M -$222M -$224M XXX
EBITDA Margin 57% -505% -703% -681% XXX
Net Profit $153M $159M -$146M XXX XXX
Net Margin 32% 417% -464% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

AbCellera Stock Performance

As of February 7, 2025, AbCellera's stock price is $3.

AbCellera has current market cap of $916M, and EV of $344M.

See AbCellera trading valuation data

AbCellera Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$344M $916M XXX XXX XXX XXX $-0.59

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

AbCellera Valuation Multiples

As of February 7, 2025, AbCellera has market cap of $916M and EV of $344M.

AbCellera's trades at 10.5x LTM EV/Revenue multiple, and -1.5x LTM EBITDA.

Analysts estimate AbCellera's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for AbCellera and 10K+ public comps

AbCellera Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $344M XXX XXX XXX
EV/Revenue 10.9x XXX XXX XXX
EV/EBITDA -1.5x XXX XXX XXX
P/E -5.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -1.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AbCellera Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

AbCellera Valuation Multiples

AbCellera's NTM/LTM revenue growth is 39%

AbCellera's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, AbCellera's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate AbCellera's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for AbCellera and other 10K+ public comps

AbCellera Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -17% XXX XXX XXX XXX
EBITDA Margin -703% XXX XXX XXX XXX
EBITDA Growth 16% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -664% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.4M XXX XXX XXX XXX
S&M Expenses to Revenue 37% XXX XXX XXX XXX
G&A Expenses to Revenue 160% XXX XXX XXX XXX
R&D Expenses to Revenue 462% XXX XXX XXX XXX
Opex to Revenue 687% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

AbCellera Public Comps

See valuation multiples for AbCellera public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Jubilant Pharmova XXX XXX XXX XXX XXX XXX
Biocon XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
Dishman Carbogen Amics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

AbCellera M&A and Investment Activity

AbCellera acquired  XXX companies to date.

Last acquisition by AbCellera was  XXXXXXXX, XXXXX XXXXX XXXXXX . AbCellera acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by AbCellera

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About AbCellera

When was AbCellera founded? AbCellera was founded in 2012.
Where is AbCellera headquartered? AbCellera is headquartered in United States of America.
How many employees does AbCellera have? As of today, AbCellera has 586 employees.
Who is the CEO of AbCellera? AbCellera's CEO is Dr. Carl L.G. Hansen, PhD.
Is AbCellera publicy listed? Yes, AbCellera is a public company listed on NAS.
What is the stock symbol of AbCellera? AbCellera trades under ABCL ticker.
When did AbCellera go public? AbCellera went public in 2020.
Who are competitors of AbCellera? Similar companies to AbCellera include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics.
What is the current market cap of AbCellera? AbCellera's current market cap is $916M
What is the current revenue of AbCellera? AbCellera's last 12-month revenue is $32.8M.
What is the current EBITDA of AbCellera? AbCellera's last 12-month EBITDA is -$224M.
What is the current EV/Revenue multiple of AbCellera? Current revenue multiple of AbCellera is 10.5x.
What is the current EV/EBITDA multiple of AbCellera? Current EBITDA multiple of AbCellera is -1.5x.
What is the current revenue growth of AbCellera? AbCellera revenue growth between 2023 and 2024 was -17%.
Is AbCellera profitable? Yes, AbCellera is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.